131 related articles for article (PubMed ID: 31264735)
1. Oximes as pretreatment before acute exposure to paraoxon.
Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA
J Appl Toxicol; 2019 Nov; 39(11):1506-1515. PubMed ID: 31264735
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of eight experimental bispyridinium oximes against paraoxon-induced mortality: comparison with the conventional oximes pralidoxime and obidoxime.
Nurulain SM; Lorke DE; Hasan MY; Shafiullah M; Kuca K; Musilek K; Petroianu GA
Neurotox Res; 2009 Jul; 16(1):60-7. PubMed ID: 19526299
[TBL] [Abstract][Full Text] [Related]
3. Combined Pre- and Posttreatment of Paraoxon Exposure.
Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA
Molecules; 2020 Mar; 25(7):. PubMed ID: 32230733
[TBL] [Abstract][Full Text] [Related]
4. Experimental and Established Oximes as Pretreatment before Acute Exposure to Azinphos-Methyl.
Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802843
[TBL] [Abstract][Full Text] [Related]
5. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon.
Petroianu GA; Nurulain SM; Nagelkerke N; Shafiullah M; Kassa J; Kuca K
J Appl Toxicol; 2007; 27(5):453-7. PubMed ID: 17304644
[TBL] [Abstract][Full Text] [Related]
6. Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity.
Lorke DE; Nurulain SM; Hasan MY; Kuca K; Musilek K; Petroianu GA
J Appl Toxicol; 2008 Oct; 28(7):920-8. PubMed ID: 18548743
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.
Lorke DE; Hasan MY; Nurulain SM; Kuca K; Schmitt A; Petroianu GA
Toxicol Mech Methods; 2009 May; 19(4):327-33. PubMed ID: 19778224
[TBL] [Abstract][Full Text] [Related]
8. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
[TBL] [Abstract][Full Text] [Related]
9. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon.
Petroianu GA; Nurulain SM; Shafiullah M; Hasan MY; Kuča K; Lorke DE
J Appl Toxicol; 2013 Sep; 33(9):894-900. PubMed ID: 22611016
[TBL] [Abstract][Full Text] [Related]
11. In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication.
Arshad M; Fatmi MQ; Musilek K; Hussain A; Kuca K; Petroianu G; Kalasz H; Nurulain SM
Toxicol Mech Methods; 2018 Jan; 28(1):62-68. PubMed ID: 28722512
[TBL] [Abstract][Full Text] [Related]
12. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
Petroianu GA; Arafat K; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
[TBL] [Abstract][Full Text] [Related]
13. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure?
Lorke DE; Petroianu GA
J Appl Toxicol; 2009 Aug; 29(6):459-69. PubMed ID: 19603416
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by Paraoxon.
Kuca K; Jun D; Junova L; Musilek K; Hrabinova M; da Silva JAV; Ramalho TC; Valko M; Wu Q; Nepovimova E; França TCC
Molecules; 2018 May; 23(5):. PubMed ID: 29735900
[TBL] [Abstract][Full Text] [Related]
15. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
[TBL] [Abstract][Full Text] [Related]
16. The Experimental Oxime K027-A Promising Protector From Organophosphate Pesticide Poisoning. A Review Comparing K027, K048, Pralidoxime, and Obidoxime.
Lorke DE; Petroianu GA
Front Neurosci; 2019; 13():427. PubMed ID: 31191210
[TBL] [Abstract][Full Text] [Related]
17. A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate.
Pirollo KF; Moghe M; Guan M; Rait AS; Wang A; Kim SS; Chang EH; Harford JB
Int J Nanomedicine; 2024; 19():307-326. PubMed ID: 38229703
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase inhibitors as pretreatment before acute exposure to organophosphates: assessment using methyl-paraoxon.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA
CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1052-60. PubMed ID: 23244429
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro.
Worek F; Aurbek N; Thiermann H
J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251
[TBL] [Abstract][Full Text] [Related]
20. The influence of obidoxime, diacetylmonoxime, pralidoxime, and two less hydrophilic derivatives of pralidoxime upon the cholinesterase inhibition and the pressor effect by paraoxon in the rat.
de Neef JH; Porsius AJ
Toxicol Appl Pharmacol; 1982 Nov; 66(2):244-51. PubMed ID: 6761901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
